Top

Gepubliceerd in:

2008 | OriginalPaper | Hoofdstuk

18 Spierziekten

Auteur : Dr. T. Takken

Gepubliceerd in: Inspanningsfysiologie bij kinderen

Uitgeverij: Bohn Stafleu van Loghum

Samenvatting

Spierziekten is een verzamelnaam voor een groot aantal verschillende aandoeningen. In het verleden was het beleid inzake testen en trainen van patiënten met een spierziekte zeer behoudend, omdat er altijd een risico bestaat dat de gezondheidstoestand van de patiënten door de training verslechtert.

vorige hoofdstuk 17 Osteogenesis imperfecta

volgende hoofdstuk 19 Spina bifida

Alexanderson H, Stenstrom CH, Jenner G, Lundberg I. The safety of a resistive home exercise program in patients with recent onset active polymyositis or dermatomyositis. Scand J Rheumatol. 2000;29:295-301.PubMedCrossRef

Alexanderson H, Stenstrom CH, Lundberg I. Safety of a home exercise programme in patients with polymyositis and dermatomyositis: a pilot study. Rheumatology (Oxford). 1999;38:608-11.CrossRef

Ansved T. Muscular dystrophies: influence of physical conditioning on the disease evolution. Curr Opin Clin Nutr Metab Care. 2003;6:435-9.PubMed

Arnardottir S, Alexanderson H, Lundberg IE, Borg K. Sporadic inclusion body myositis: pilot study on the effects of a home exercise program on muscle function, histopathology and inflammatory reaction. J Rehabil Med. 2002;35:31-5.CrossRef

Biring MS, Fournier M, Ross DJ, Lewis MI. Cellular adaptations of skeletal muscles to cyclosporine. J Appl Physiol. 1998;84:1967-75.PubMed

Braakhekke JP, Bruin MI de, Stegeman DF, Wevers RA, Binkhorst RA, Joosten EM. The second wind phenomenon in McArdle’s disease. Brain. 1986;109 (Pt 6):1087-101.PubMedCrossRef

Carter SL, Rennie CD, Hamilton SJ, Tarnopolsky MA. Changes in skeletal muscle in males and females following endurance training. Can J Physiol Pharmacol. 2001;79:386-92.PubMedCrossRef

Cejudo P, Bautista J, Montemayor T, Villagomez R, Jimenez L, Ortega F, et al. Exercise training in mitochondrial myopathy: a randomized controlled trial. Muscle Nerve. 2005;32:342-50.PubMedCrossRef

Coyle EF. Substrate utilization during exercise in active people. Am J Clin Nutr. 1995;61:S968-79.

Duncan GE, Perkins LA, Theriaque DW, Neiberger RE, Stacpoole PW. Dichloroacetate therapy attenuates the blood lactate response to submaximal exercise in patients with defects in mitochondrial energy metabolism. J Clin Endocrinol Metab. 2004;89:1733-8.PubMedCrossRef

Esbjornsson-Liljedahl M, Dasmalchi M, Alexanderson H, Stahlberg M, Lundberg IE. Changed muscle morphology in myositis patients following a home exercise program. In: Klarlund Petersen B, Febbraio M, Fleshner M, editors. 6th International Society of Exercise Immunology Symposium;. 2003; Copenhagen, Danmark; 2003. p. 47.

Haller RG, Bertocci LA. Exercise evaluation of metabolic myopathies. In: Engel AG, Franzini-Armstrong C, editors. Myology. 2nd ed. New York: McGraw-Hill; 1994. pp. 807-21.

Haller RG, Vissing J. No spontaneous second wind in muscle phosphofructokinase deficiency. Neurology. 2004;62:82-6.PubMedCrossRef

Haller RG, Wyrick P, Cavender D, Wall A, Vissing J. Aerobic conditioning: an effective therapy in McArdle’s disease. Neurology. 1998;50:p. A369.CrossRef

Hebert CA, Byrnes TJ, Baethge BA, Wolf RE, Kinasewitz GT. Exercise limitation in patients with polymyositis. Chest. 1990;98:352-7.PubMedCrossRef

Hicks JE, Drinkard B, Summers RM, Rider LG. Decreased aerobic capacity in children with juvenile dermatomyositis. Arthritis Rheum. 2002;47:118-23.PubMedCrossRef

Hickson RC, Marone JR. Exercise and inhibition of glucocorticoid-induced muscle atrophy. Exerc Sport Sci Rev. 1993;21:135-67.PubMedCrossRef

Horber FF, Scheidegger JR, Grunig BE, Frey FJ. Evidence that prednisone-induced myopathy is reversed by physical training. J Clin Endocrinol Metab. 1985;61:83-8.PubMedCrossRef

Huber AM, Hicks JE, Lachenbruch PA, Perez MD, Zemel LS, Rennebohm RM, et al. Validation of the Childhood Health Assessment Questionnaire in the juvenile idiopathic myopathies. Juvenile Dermatomyositis Disease Activity Collaborative Study Group. J Rheumatol. 2001;28:1106-11.PubMed

Kooi EL van der, Vogels OJ, van Asseldonk RJ, Lindeman E, Hendriks JC, Wohlgemuth M, et al. Strength training and albuterol in facioscapulohumeral muscular dystrophy. Neurology. 2004;63:702-8.PubMedCrossRef

Lovell DJ, Lindsley CB, Rennebohm RM, Ballinger SH, Bowyer SL, Giannini EH, et al. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. ii. The Childhood Myositis Assessment Scale (cmas): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Arthritis Rheum. 1999;42:2213-9.PubMedCrossRef

Maillard S. Quantitative Assessment of the Effects of Exercise on Muscles in Children with Dermatomyositis [msc]. London: City University; 2002.

McDonald CM, Widman LM, Walsh DD, Walsh SA, Abresch RT. Use of step activity monitoring for continuous physical activity assessment in boys with Duchenne muscular dystrophy. Arch Phys Med Rehabil. 2005;86:802-8.PubMedCrossRef

Ollivier K, Hogrel J-Y, Gomez-Merino D, Romero NR, Laforêt P, Eymard B, et al. Exercise tolerance and daily life in McArdle’s disease. Muscle & Nerve. 2005;31:637-41.CrossRef

Olsen DB, Orngreen MC, Vissing J. Aerobic training improves exercise performance in facioscapulohumeral muscular dystrophy. Neurology. 2005;64:1064-6.PubMedCrossRef

Orngreen M, Norgaard MG, Sacchetti M, Engelen BG van, Vissing J. Fuel utilization in patients with very long-chain acyl-coa dehydrogenase deficiency. Ann Neurol. 2004;56:279-83.PubMedCrossRef

Orngreen MC, Duno M, Ejstrup R, Christensen E, Schwartz M, Sacchetti M, et al. Fuel utilization in subjects with carnitine palmitoyltransferase 2 gene mutations. Ann Neurol. 2005;57:60-6.PubMedCrossRef

Orngreen MC, Ejstrup R, Vissing J. Effect of diet on exercise tolerance in carnitine palmitoyltransferase ii deficiency. Neurology. 2003;61:559-61.PubMedCrossRef

Pachman LM. Juvenile dermatomyositis. Pathophysiology and disease expression. Pediatr Clin North Am. 1995;42:1071-98.PubMed

Park JH, Niermann KJ, Ryder NM, Nelson AE, Das A, Lawton AR, et al. Muscle abnormalities in juvenile dermatomyositis patients: P-31 magnetic resonance spectroscopy studies. Arthritis Rheum. 2000;43:2359-67.PubMedCrossRef

Phillips BA, Mastaglia FL. Exercise therapy in patients with myopathy. Curr Opin Neurol. 2000;13:547-52.PubMedCrossRef

Resnick JS, Mammel M, Mundale MO, Kottke FJ. Muscular strength as an index of response to therapy in childhood dermatomyositis. Arch Phys Med Rehabil. 1981;62:12-9.PubMed

Shephard RJ, Allen C, Benade AJ, Davies CT, Di Prampero PE, Hedman R, et al. The maximum oxygen intake. An international reference standard of cardiorespiratory fitness. Bull World Health Organ. 1968;38:757-64.PubMedCentralPubMed

Siciliano G, Manca ML, Renna M, Prontera C, Mercuri A, Murri L. Effects of aerobic training on lactate and catecholaminergic exercise responses in mitochondrial myopathies. Neuromuscul Disord. 2000;10:40-5.PubMedCrossRef

Silva AC, Russo AK, Picarro IC, Schmidt B, Gabbai A, Oliveira AS, et al. Cardiorespiratory responses to exercise in patients with spinal muscular atrophy and limb-girdle dystrophy. Braz J Med Biol Res. 1987;20:565-8.PubMed

Sockolov R, Irwin B, Dressendorfer RH, Bernauer EM. Exercise performance in 6-to-11-year-old boys with Duchenne muscular dystrophy. Arch Phys Med Rehabil. 1977;58:195-201.PubMed

Taivassalo T, De Stefano N, Chen J, Karpati G, Arnold DL, Argov Z. Short-term aerobic training response in chronic myopathies. Muscle Nerve. 1999a;22:1239-43.PubMedCrossRef

Taivassalo T, Fu K, Johns T, Arnold D, Karpati G, Shoubridge EA. Gene shifting: a novel therapy for mitochondrial myopathy. Hum Mol Genet. 1999b;8:1047-52.PubMedCrossRef

Taivassalo T, Haller RG. Implications of exercise training in mtdna defects – use it or lose it? Biochim Biophys Acta. 2004;1659:221-31.PubMedCrossRef

Taivassalo T, Jensen TD, Kennaway N, DiMauro S, Vissing J, Haller RG. The spectrum of exercise tolerance in mitochondrial myopathies: a study of 40 patients. Brain. 2003;126:413-23.PubMedCrossRef

Taivassalo T, Shoubridge EA, Chen J, Kennaway NG, DiMauro S, Arnold DL, et al. Aerobic conditioning in patients with mitochondrial myopathies: physiological, biochemical, and genetic effects. Ann Neurol. 2001;50:133-41.PubMedCrossRef

Takken T, Custers J, Visser G, Dorland L, Helders P, Koning T de. Prolonged exercise testing in two children with a mild Multiple Acyl-CoA-Dehydrogenase deficiency. Nutr Metab (Lond). 2005a;2:12.CrossRef

Takken T, Net J van der, Engelbert RH, Pater S, Helders PJM. Responsiveness of exercise parameters in children with inflammatory myositis. Arthritis and Rheumatism. In press 2007.

Takken T, Net J van der, Helders PJ. Anaerobic exercise capacity in patients with juvenile-onset idiopathic inflammatory myopathies. Arthritis Rheum. 2005b;53:173-7.PubMedCrossRef

Takken T, Spermon N, Helders PJ, Prakken AB, Net J van der. Aerobic exercise capacity in patients with juvenile dermatomyositis. J Rheumatol. 2003;30:1075-80.PubMed

Tarnopolsky M. Exercise testing as a diagnostic entity in mitochondrial myopathies. Mitochondrion. 2004;4:529-42.PubMedCrossRef

Tirosh E, Bar-Or O, Rosenbaum P. New muscle power test in neuromuscular disease. Feasibility and reliability. Am J Dis Child. 1990;144:1083-7.PubMedCrossRef

us Department of Health and Human Services. Physical Activity and Health: A Report of the Surgeon General. Atlanta, GA: U.S.: Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion; 1996.

Vignos PJ, Jr., Watkins MP. The effect of exercise in muscular dystrophy. jama. 1966;197:843-8.PubMedCrossRef

Vissing J, Gansted U, Quistorff B. Exercise intolerance in mitochondrial myopathy is not related to lactic acidosis. Ann Neurol. 2001;49:672-6.PubMedCrossRef

Vissing J, Haller RG. A diagnostic cycle test for McArdle’s disease. Ann Neurol. 2003a;54:539-42.PubMedCrossRef

Vissing J, Haller RG. The effect of oral sucrose on exercise tolerance in patients with McArdle’s disease. N Engl J Med. 2003b;349:2503-9.PubMedCrossRef

Wiesinger GF, Quittan M, Aringer M, Seeber A, Volc-Platzer B, Smolen J, et al. Improvement of physical fitness and muscle strength in polymyositis/dermatomyositis patients by a training programme. Br J Rheumatol. 1998a;37:196-200.PubMedCrossRef

Wiesinger GF, Quittan M, Graninger M, Seeber A, Ebenbichler G, Sturm B, et al. Benefit of 6 months long-term physical training in polymyositis/dermatomyositis patients. Br J Rheumatol. 1998b;37:1338-42.PubMedCrossRef

Wiesinger GF, Quittan M, Nuhr M, Volc-Platzer B, Ebenbichler G, Zehetgruber M, et al. Aerobic capacity in adult dermatomyositis/polymyositis patients and healthy controls. Arch Phys Med Rehabil. 2000;81:1-5.PubMedCrossRef

Titel: 18 Spierziekten
Auteur: Dr. T. Takken
Uitgeverij: Bohn Stafleu van Loghum
Boek: Inspanningsfysiologie bij kinderen
Print ISBN: 978-90-313-5084-1

Elektronisch ISBN: 978-90-313-6560-9

Copyright: 2008
DOI: https://doi.org/10.1007/978-90-313-6560-9_18

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Samenvatting

Log in om toegang te krijgen